e-drug
[Top] [All Lists]

[no subject]

Subject: Could Mefin in Tanzania be substandard? (cont'd)

E-drug: Could Mefin in Tanzania be substandard? (cont'd)
---------------------------------------------

It is difficult to judge the substandard potential of Mefin as such.
However it is
interesting to notice that on Thursday, July 17, 1997, in the East African
Standard, a Kenyan newspaper, was posted a full page notice which title
was:
"Important notice relating to trademark infringement and trade in
counterfeit" on
Metakelfin.

To summarize, the notice was presenting the case of a counterfeit
Metakelfin
and compared it with the original. The posting was presented as a
"collaborative
public health campaign between Pharmacia & Upjohn and the MOH - GOK, The
Pharmacy and Poisons board as well as the National Quality control
Laboratory".

We know that counterfeit drugs, substandard or not, are an increased common
practice in developing countries. If the problem happened to Metakelfin, so
why
not to Mefin?

Testing the product is an interesting action to be done. You could also
first
control with the manufacturer that the manufacturing date, the expiration
date
and the batch number are not fake and really originated from the known
manufacturer.

Best regards,

Pascal Olle
ICRC Geneva
e-mail: polle@icrc.org
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.

<Prev in Thread] Current Thread [Next in Thread>
  • [no subject], Pascal Olle <=